Search Results - "Schulthess, F. T"
-
1
Purinergic P2X₇ receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival
Published in Diabetologia (01-08-2009)“…Aims/hypothesis In obesity, beta cells activate compensatory mechanisms to adapt to the higher insulin demand. Interleukin-1 receptor antagonist (IL-1Ra)…”
Get full text
Journal Article -
2
Identification of ALOX5 as a gene regulating adiposity and pancreatic function
Published in Diabetologia (01-06-2008)“…Aims/hypothesis We previously used an integrative genetics approach to demonstrate that 5-lipoxygenase (5-LO) deficiency in mice (Alox5 ⁻/⁻) protects against…”
Get full text
Journal Article -
3
Erratum to: Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival
Published in Diabetologia (01-09-2015)Get full text
Journal Article -
4
TOSO promotes β-cell proliferation and protects from apoptosis
Published in Molecular metabolism (Germany) (01-12-2012)“…Abstract Decreased β-cell mass reflects a shift from quiescence/proliferation into apoptosis, it plays a crucial role in the pathophysiology of diabetes. A…”
Get full text
Journal Article -
5
Expression of Concern: Deletion of the Mitochondrial Flavoprotein Apoptosis Inducing Factor (AIF) Induces β-Cell Apoptosis and Impairs β-Cell Mass
Published in PloS one (25-08-2022)“…The corresponding author stated that the leftmost b-Actin panel in Fig 1A in [1], which served as loading control for the protein lysates of isolated islets…”
Get full text
Journal Article -
6
Erratum to: Purinergic P2X^sub 7^ receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival
Published in Diabetologia (01-09-2015)Get full text
Journal Article -
7
Purinergic P2X sub(7) receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival
Published in Diabetologia (01-08-2009)“…Aims/hypothesis: In obesity, beta cells activate compensatory mechanisms to adapt to the higher insulin demand. Interleukin-1 receptor antagonist (IL-1Ra)…”
Get full text
Journal Article